Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Semagacestat> ?p ?o. }
Showing items 1 to 76 of
76
with 100 items per page.
- Semagacestat abstract "Semagacestat (LY450139) was a candidate drug for a causal therapy against Alzheimer's disease. It was originally developed by Eli Lilly and Élan, and clinical trials were conducted by Eli Lilly. Phase III trials included over 3000 patients, but in August 2010, a disappointing interim analysis, in which semagacestat performed worse than the placebo, led to the trials being stopped.".
- Semagacestat atcPrefix "none".
- Semagacestat casNumber "425386-60-3".
- Semagacestat fdaUniiCode "3YN0602W4W".
- Semagacestat iupacName "(2S)-2-hydroxy-3-methyl-N-((1S)-1-methyl-2-{[(1S)-3-methyl-2-oxo-2,3,4,5-tetrahydro-1H-3-benzazepin-1-yl]amino}-2-oxoethyl)butanamide".
- Semagacestat pubchem "9843750".
- Semagacestat thumbnail Semagacestat_structure.svg?width=300.
- Semagacestat wikiPageID "18860929".
- Semagacestat wikiPageRevisionID "600897110".
- Semagacestat atcPrefix "none".
- Semagacestat c "19".
- Semagacestat casNumber "425386".
- Semagacestat chembl "520733".
- Semagacestat eliminationHalfLife "8640.0".
- Semagacestat excretion "87".
- Semagacestat h "27".
- Semagacestat hasPhotoCollection Semagacestat.
- Semagacestat iupacName "-2".
- Semagacestat kegg "D09377".
- Semagacestat legalStatus "Abandoned".
- Semagacestat metabolism CYP3A4.
- Semagacestat metabolism CYP3A5.
- Semagacestat molecularWeight "361.434".
- Semagacestat n "3".
- Semagacestat o "4".
- Semagacestat pregnancyCategory "N/A".
- Semagacestat pubchem "9843750".
- Semagacestat routesOfAdministration "Oral".
- Semagacestat smiles "c12ccccc2CCNCC1NCCNCCCC".
- Semagacestat synonyms "LY-450139".
- Semagacestat unii "3".
- Semagacestat verifiedrevid "443328897".
- Semagacestat subject Category:Alcohols.
- Semagacestat subject Category:Alzheimer's_disease.
- Semagacestat subject Category:Amides.
- Semagacestat subject Category:Antidementia_agents.
- Semagacestat subject Category:Benzazepines.
- Semagacestat subject Category:Eli_Lilly_and_Company.
- Semagacestat subject Category:Lactams.
- Semagacestat type Abstraction100002137.
- Semagacestat type Agent114778436.
- Semagacestat type Alcohol107884567.
- Semagacestat type Alcohols.
- Semagacestat type Amide114724264.
- Semagacestat type Amides.
- Semagacestat type Beverage107881800.
- Semagacestat type CausalAgent100007347.
- Semagacestat type Chemical114806838.
- Semagacestat type Compound114818238.
- Semagacestat type Drug103247620.
- Semagacestat type DrugOfAbuse103248958.
- Semagacestat type Fluid114939900.
- Semagacestat type Food100021265.
- Semagacestat type Liquid114940386.
- Semagacestat type Material114580897.
- Semagacestat type Matter100020827.
- Semagacestat type OrganicCompound114727670.
- Semagacestat type Part113809207.
- Semagacestat type PhysicalEntity100001930.
- Semagacestat type Relation100031921.
- Semagacestat type Substance100019613.
- Semagacestat type Substance100020090.
- Semagacestat type Drug.
- Semagacestat type DrugProduct.
- Semagacestat type FunctionalSubstance.
- Semagacestat comment "Semagacestat (LY450139) was a candidate drug for a causal therapy against Alzheimer's disease. It was originally developed by Eli Lilly and Élan, and clinical trials were conducted by Eli Lilly. Phase III trials included over 3000 patients, but in August 2010, a disappointing interim analysis, in which semagacestat performed worse than the placebo, led to the trials being stopped.".
- Semagacestat label "Semagacestat".
- Semagacestat label "Semagacestat".
- Semagacestat sameAs Semagacestat.
- Semagacestat sameAs m.04gqsp_.
- Semagacestat sameAs Q426010.
- Semagacestat sameAs Q426010.
- Semagacestat sameAs Semagacestat.
- Semagacestat wasDerivedFrom Semagacestat?oldid=600897110.
- Semagacestat depiction Semagacestat_structure.svg.
- Semagacestat isPrimaryTopicOf Semagacestat.